Table 3.
Variables | Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | ||
Training dataset (n = 250) | |||||||
EpiLncPM | High vs. low | 50.097 | 10.231–245.312 | <0.001 | 29.050 | 5.94–142.074 | <0.001 |
Age | Old vs. young | Inf | 0-Inf | 0.998 | Inf | 0-Inf | 0.990 |
Gender | Female vs. male | 1.307 | 0.271–6.305 | 0.739 | 0.237 | 0.247–6.509 | 0.776 |
Stage | III, IV vs. I, II | 9.377 | 1.933–45.492 | 0.005 | 0.302 | 0.26–7.051 | 0.720 |
Testing dataset (n= 249) | |||||||
EpiLncPM | High vs. low | 4.395 | 0.981–19.686 | 0.053 | 3.699 | 0.813–16.833 | 0.091 |
Age | Old vs. young | Inf | 0-Inf | 0.998 | Inf | 0-Inf | 0.999 |
Gender | Female vs. male | 0.202 | 0.045–0.915 | 0.038 | 0.268 | 0.058–1.233 | 0.091 |
Stage | III, IV vs. I, II | 5.416 | 1.048–27.997 | 0.044 | 1.083 | 0.207–5.662 | 0.924 |